Related Experiment Video
Updated: Oct 4, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Wnt7a inhibits transformed cell proliferation while promoting migration and invasion in non-small cell lung cancer
Xianhua Xu1,2, Shijie Xu2,3, Zhixia Wei4
1Department of Pathology, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, China.
Background:
Non-small cell lung cancer (NSCLC) is the most important cause of lung cancer death. Wnt7a is a known tumor suppressor gene which is often downregulated in NSCLC, and restoration of Wnt7a leads to decreased NSCLC cell proliferation. However, the biological role of Wnt7a in the migration and invasion in NSCLC remains unclear.
Methods:
We examined whether overexpression of Wnt7a transfected by pcDNA6-Wnt7a could induce the proliferation, migration and invasion of NSCLC H1650 and A549 cell lines. Wnt7a signaling pathway, such as canonical (β-catenin) or non-canonical (c-Jun N-terminal kinase, JNK) pathways, were also assessed.
Results:
We found that re-expression of Wnt7a led to reduced cell growth in NSCLC cell lines. In spite of the antiproliferative effect, Wnt7a overexpression could affect the migration and invasion of NSCLC cells. In the Wnt7a signaling pathway, the phosphorylation of JNK (Thr-183/Tyr-185) and c-Jun (Ser-63) were increased by re-expression of Wnt7a in both H1650 and A549 cell lines. The phosphorylation of β-catenin (Thr-41/Ser-45, Ser-552, Ser-675, and Ser-45) were not altered by restoration of Wnt7a. In NSCLC cells, Wnt7a overexpression was accompanied by parallel changes in the JNK pathway but not in the β-catenin pathway.
Conclusions:
These results help to understand that Wnt7a may play a two-sided role in NSCLC, suggesting that restoration of Wnt7a expression is not always suitable as therapeutic strategy for NSCLC.
Insights
Wnt7a, a tumor suppressor, reduces non-small cell lung cancer (NSCLC) growth but also impacts migration and invasion. Its dual role suggests Wnt7a restoration may not always be a suitable NSCLC therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality.
- Wnt7a is recognized as a tumor suppressor gene frequently downregulated in NSCLC.
- Previous studies indicate Wnt7a restoration inhibits NSCLC cell proliferation, but its role in migration and invasion is less understood.
Purpose of the Study:
- To investigate the effect of Wnt7a overexpression on NSCLC cell proliferation, migration, and invasion.
- To elucidate the involvement of Wnt7a signaling pathways, specifically canonical (β-catenin) and non-canonical (JNK), in NSCLC.
Main Methods:
- Overexpression of Wnt7a in NSCLC cell lines (H1650 and A549) using pcDNA6-Wnt7a.
- Assessment of cell proliferation, migration, and invasion.
- Analysis of Wnt7a signaling pathway components, including β-catenin and JNK pathway proteins.
Main Results:
- Wnt7a re-expression significantly reduced NSCLC cell growth.
- Despite antiproliferative effects, Wnt7a overexpression influenced NSCLC cell migration and invasion.
- Wnt7a restoration increased JNK pathway activation (phosphorylation of JNK and c-Jun) but did not affect β-catenin pathway components.
Conclusions:
- Wnt7a exhibits a dual role in NSCLC, inhibiting proliferation while potentially promoting migration and invasion.
- The Wnt7a-mediated effects on NSCLC cells are associated with the JNK signaling pathway, not the canonical β-catenin pathway.
- Restoring Wnt7a expression may not be a universally effective therapeutic strategy for NSCLC due to its complex biological functions.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Cancer Cell Migration through Invadopodia
lncRNA - Long Non-coding RNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

